Oral SGLT2 Inhibitors Reverse MASLD in Diabetes Oral SGLT2 Inhibitors Reverse MASLD in Diabetes
Among oral antidiabetic drugs, SGLT2 inhibitors were linked to better liver outcomes in patients with both diabetes and MASLD in a new study.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
More News: Diabetes | Endocrinology | Health | Liver | SGLT2 Inhibitors | Study | Urology & Nephrology